The aim of this study was to compare the biodistribution of the 68Ga-labeled PSMA ligands 617, I&T and 11 in non-tumor compartments and in tumor lesions, and to evaluate the influence of the biodistribution on the detection rate of tumor lesions in patients suffering from the biochemical recurrence of prostate cancer. The gene discussed is FOLH1; the disease is prostate cancer.